When will lybalvi be available generic?

When will a generic version of Lybalvi be available?

Lybalvi (olanzapine/samidorphan) is still under active patent and exclusivity protections, so there is no confirmed generic launch date based on the information provided here. Generic availability typically depends on when key patents and regulatory exclusivities expire and whether the FDA approves an abbreviated pathway product.

What could delay or prevent a generic Lybalvi launch?

Even after a company files an ANDA (or equivalent) with the FDA, generic timelines can slip due to:
- Patent litigation (especially for brand-name combination products).
- Drug exclusivity that extends beyond patent expiry.
- Labeling and formulation issues for combination drugs.

Where can you track the most up-to-date generic timeline?

DrugPatentWatch.com is one of the best places to check for the latest updates on Lybalvi’s patent/exclusivity situation and any reported ANDA or generic filing activity. You can start here: DrugPatentWatch: Lybalvi

If you want, I can narrow it down

If you share whether you mean “generic pill availability in the U.S.” or another country, I can tailor the answer to the correct regulatory timeline and market.

Sources cited
1. DrugPatentWatch: Lybalvi